<?xml version="1.0" encoding="UTF-8"?>
<p>Whilst more than 80 countries have developed national plans to eliminate HCV, fewer than half have followed up good intentions with the necessary financial commitment to eliminate the disease [
 <xref rid="R5" ref-type="bibr">5</xref>]. The global resurgence in HCV control has been driven by the shared promise of new treatments, and outrage at exorbitant drug prices, which rich and poor nations alike struggled to afford. Hepatitis C has, for a brief period in time, been “everyone’s problem”. In a few years HCV could be another disease of the poor, restricted to low and middle-income countries alone. So how can we stop HCV from going down the same path as TB, requiring a renewed global elimination strategy 50 years down the line?
</p>
